癌症免疫疗法，第二部分：疗效、安全性及其他临床考量
Cancer Immunotherapy, Part 2: Efficacy, Safety, and Other Clinical Considerations.
作者信息
Ventola C Lee
出版信息
P T. 2017 Jul;42(7):452-463.
Abstract
This article, the second in a series of three, provides an overview of the efficacy and safety of cancer immunotherapies ranging from monoclonal antibodies to vaccines, including additional clinical considerations regarding immune checkpoint blockers.
摘要
本文是三篇系列文章中的第二篇，概述了从单克隆抗体到疫苗等癌症免疫疗法的疗效和安全性，包括有关免疫检查点阻断剂的更多临床考量。
相似文献
1
Cancer Immunotherapy, Part 2: Efficacy, Safety, and Other Clinical Considerations.癌症免疫疗法，第二部分：疗效、安全性及其他临床考量
P T. 2017 Jul;42(7):452-463.
2
Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.当前和未来新型免疫疗法在泌尿肿瘤学中的应用：文献综述的批判性评价。
Eur Urol Focus. 2018 Apr;4(3):442-454. doi: 10.1016/j.euf.2017.10.001. Epub 2017 Oct 19.
3
Promising immunotherapies for esophageal cancer.食管癌有前景的免疫疗法。
Expert Opin Biol Ther. 2017 Jun;17(6):723-733. doi: 10.1080/14712598.2017.1315404. Epub 2017 Apr 11.
4
Immunotherapy for the Treatment of Urothelial Carcinoma.免疫疗法治疗尿路上皮癌。
J Urol. 2017 Jan;197(1):14-22. doi: 10.1016/j.juro.2016.02.3005. Epub 2016 Jul 25.
5
From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?从患者权益倡导者的角度来看：癌症免疫疗法是否代表了一种范式转变？
Curr Oncol Rep. 2018 Feb 7;20(1):8. doi: 10.1007/s11912-018-0662-5.
6
Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.免疫疗法在靶向多发性骨髓瘤骨髓微环境中的作用：一种不断发展的治疗策略。
Pharmacotherapy. 2017 Jan;37(1):129-143. doi: 10.1002/phar.1871. Epub 2017 Jan 6.
7
Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies.定义最佳的小鼠模型以研究免疫检查点抑制剂及其与其他免疫疗法的联合应用。
Ann Oncol. 2016 Jul;27(7):1190-8. doi: 10.1093/annonc/mdw041. Epub 2016 Feb 23.
8
[Immunotherapies - Overview, mode of action and clinical implications].[免疫疗法——概述、作用机制及临床意义]
Ther Umsch. 2019 Sep;76(4):187-194. doi: 10.1024/0040-5930/a001083.
9
Vaccines versus immunotherapy: overview of approaches in deciding between options.疫苗与免疫疗法：在两种选择之间做出决定的方法概述。
Hum Vaccin Immunother. 2014;10(11):3369-74. doi: 10.4161/21645515.2014.980707.
10
Cancer immunotherapy: from the lab to clinical applications-Potential impact on cancer centres' organisation.癌症免疫疗法：从实验室到临床应用——对癌症中心组织架构的潜在影响
Ecancermedicalscience. 2016 Nov 10;10:691. doi: 10.3332/ecancer.2016.691. eCollection 2016.
引用本文的文献
1
ImmuProgML: machine learning-based dissection of cancer-immune dynamics during tumor progression to improve immunotherapy.免疫进展机器学习（ImmuProgML）：基于机器学习剖析肿瘤进展过程中的癌症免疫动力学以改善免疫治疗。
J Transl Med. 2025 Jul 25;23(1):826. doi: 10.1186/s12967-025-06872-x.
2
Decoding the immune landscape in Ewing sarcoma pathogenesis: The role of tumor infiltrating immune cells and immune milieu.解析尤因肉瘤发病机制中的免疫格局：肿瘤浸润免疫细胞和免疫微环境的作用
J Bone Oncol. 2025 Mar 31;52:100678. doi: 10.1016/j.jbo.2025.100678. eCollection 2025 Jun.
3
The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives.癌症免疫疗法的演变：对其历史和当前观点的全面综述。
Korean J Clin Oncol. 2024 Dec;20(2):51-73. doi: 10.14216/kjco.24009. Epub 2024 Dec 31.
4
The relevance of tumor target expression levels on IgA-mediated cytotoxicity in cancer immunotherapy.肿瘤靶点表达水平在癌症免疫治疗中对IgA介导的细胞毒性的相关性。
Cancer Immunol Immunother. 2024 Oct 3;73(12):238. doi: 10.1007/s00262-024-03824-0.
5
Revolutionizing Cancer Treatment: Unleashing the Power of Viral Vaccines, Monoclonal Antibodies, and Proteolysis-Targeting Chimeras in the New Era of Immunotherapy.变革癌症治疗：在免疫治疗新时代释放病毒疫苗、单克隆抗体和蛋白酶靶向嵌合体的力量。
ACS Omega. 2024 Feb 5;9(7):7277-7295. doi: 10.1021/acsomega.3c06501. eCollection 2024 Feb 20.
6
The Impact of Modern Dietary Practices on Cancer Risk and Progression: A Systematic Review.现代饮食习惯对癌症风险和进展的影响：一项系统综述。
Cureus. 2023 Oct 7;15(10):e46639. doi: 10.7759/cureus.46639. eCollection 2023 Oct.
7
Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives.肺癌治疗中的收益与风险平衡：患者对肺癌治疗方案的偏好
Front Psychol. 2023 Jun 21;14:1062830. doi: 10.3389/fpsyg.2023.1062830. eCollection 2023.
8
Borrowing Concurrent Information from Non-Concurrent Control to Enhance Statistical Efficiency in Platform Trials.从非同期对照中借用同期信息以提高平台试验的统计效率。
Curr Oncol. 2023 Mar 31;30(4):3964-3973. doi: 10.3390/curroncol30040300.
9
Drug Delivery Systems for Localized Cancer Combination Therapy.用于局部癌症联合治疗的药物输送系统。
ACS Appl Bio Mater. 2023 Mar 20;6(3):934-950. doi: 10.1021/acsabm.2c00973. Epub 2023 Feb 15.
10
Biomaterial-Based In Situ Cancer Vaccines.基于生物材料的原位癌症疫苗。
Adv Mater. 2024 Oct;36(43):e2210452. doi: 10.1002/adma.202210452. Epub 2023 Apr 25.
本文引用的文献
1
Ruxolitinib in steroid refractory graft-vs.-host disease: a case report.鲁索替尼治疗类固醇难治性移植物抗宿主病：一例报告
J Hematol Oncol. 2016 Aug 8;9(1):67. doi: 10.1186/s13045-016-0298-6.
2
The development of immunotherapy in older adults: New treatments, new toxicities?老年人群体中的免疫疗法发展：新疗法，新毒性？
J Geriatr Oncol. 2016 Sep;7(5):325-33. doi: 10.1016/j.jgo.2016.05.007. Epub 2016 Jun 16.
3
A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy.癌症治疗中现代免疫检查点抑制剂毒性管理的多学科方法。
Melanoma Res. 2016 Oct;26(5):469-80. doi: 10.1097/CMR.0000000000000273.
4
Toxicities of chimeric antigen receptor T cells: recognition and management.嵌合抗原受体T细胞的毒性：识别与管理
Blood. 2016 Jun 30;127(26):3321-30. doi: 10.1182/blood-2016-04-703751. Epub 2016 May 20.
5
Current Challenges in Cancer Treatment.癌症治疗中的当前挑战
Clin Ther. 2016 Jul;38(7):1551-66. doi: 10.1016/j.clinthera.2016.03.026. Epub 2016 May 2.
6
Advances in Therapeutic Cancer Vaccines.治疗性癌症疫苗的进展。
Adv Immunol. 2016;130:191-249. doi: 10.1016/bs.ai.2015.12.001. Epub 2016 Jan 19.
7
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper.免疫检查点阻断相关性免疫毒性的管理：一份合作立场文件。
Ann Oncol. 2016 Apr;27(4):559-74. doi: 10.1093/annonc/mdv623. Epub 2015 Dec 28.
8
Recent advances in the field of anti-cancer immunotherapy.抗癌免疫疗法领域的最新进展。
BBA Clin. 2015 Apr 18;3:280-8. doi: 10.1016/j.bbacli.2015.04.001. eCollection 2015 Jun.
9
Cancer immunology for the clinician.临床医生的癌症免疫学
Clin Adv Hematol Oncol. 2015 May;13(5):299-306.
10
Cancer immunotherapy: harnessing the immune system to battle cancer.癌症免疫疗法：利用免疫系统对抗癌症。
J Clin Invest. 2015 Sep;125(9):3335-7. doi: 10.1172/JCI83871. Epub 2015 Sep 1.
Zotero 插件